MedTrace Logo

Comparison of Albuterol for Status Asthmaticus

NCT02966184 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2021-05-20

Study results available
· View outcomes & findings →

Summary

This study is designed to compare the length of continuous albuterol administration between two different albuterol formulations, BAC containing albuterol versus preservative free albuterol.

Conditions

  • Status Asthmaticus

Interventions

DRUG

preservative free albuterol

Preservative free albuterol for nebulization

Sponsors & Collaborators

  • Norton Healthcare

    lead OTHER

Principal Investigators

  • Tristan Murray, PharmD · Norton Healthcare

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-10
Primary Completion
2018-10-25
Completion
2018-10-25
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02966184 on ClinicalTrials.gov